These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8361902

  • 1. [Activation of the fibrinolytic system following subcutaneous administration and inhalation of heparin].
    Psuja P, Tokarz A, Turowiecka Z, Sowier J, Zawilska K.
    Pol Tyg Lek; ; 48(5-6):105-8. PubMed ID: 8361902
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G, Brand P, Meyer T, Herpich C, Müllinger B, Brom J, Weidinger G, Kohlhäufl M, Häussinger K, Spannagl M, Schramm W, Siekmeier R.
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [Abstract] [Full Text] [Related]

  • 3. [Activation of the endogenous fibrinolytic system using intra-arterial heparin therapy in acute deep venous thrombosis].
    Fontányi S.
    Phlebologie; 1990 Nov; 43(1):167-72. PubMed ID: 2353043
    [Abstract] [Full Text] [Related]

  • 4. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F, Piro D, Rossiello MR, Ammollo T, Colucci M.
    Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 8. Plasma fibrinolytic activity following oral anabolic steroid therapy.
    Walker ID, Davidson JF, Young P, Conkie JA.
    Thromb Diath Haemorrh; 1975 Sep 30; 34(1):236-45. PubMed ID: 1103357
    [Abstract] [Full Text] [Related]

  • 9. [Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin].
    Kudriashov BA, Liapina LA, Ul'ianov AM.
    Vopr Med Khim; 1978 Sep 30; 24(2):255-60. PubMed ID: 149422
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ, Boon GI, Jansen JW, Bouma BN.
    Thromb Haemost; 1993 Apr 01; 69(4):381-6. PubMed ID: 8497851
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 01; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV, Howes J, Sharma V, Kadziola Z.
    Thromb Haemost; 2000 Apr 01; 83(4):523-9. PubMed ID: 10780310
    [Abstract] [Full Text] [Related]

  • 15. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
    Sartori MT, Rigotti P, Marchini F, Spiezia L, Baldan N, Furian L, Varvarikis C, Girolami A.
    Transplantation; 2003 Apr 15; 75(7):994-8. PubMed ID: 12698086
    [Abstract] [Full Text] [Related]

  • 16. Effect of syringe size on bruising following subcutaneous heparin injection.
    Hadley SA, Chang M, Rogers K.
    Am J Crit Care; 1996 Jul 15; 5(4):271-6. PubMed ID: 8811149
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Non-enzymatic fibrinolytic agents].
    Nilsson IM, Hedner U.
    Ann Anesthesiol Fr; 1978 Jul 15; 19(8):697-702. PubMed ID: 31113
    [Abstract] [Full Text] [Related]

  • 20. [A trial of the use of low-molecular-weight heparin (fraksiparin) in myocardial infarct].
    Savenkov MP, Borshchevskaia MV, Gvozdkov AL, Semenova EN.
    Ter Arkh; 1996 Jul 15; 68(8):8-12. PubMed ID: 9019842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.